Malignant Neoplasm
1 competing product in clinical development for Malignant Neoplasm.
Pipeline by Phase
Phase 1/21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Patritumab Deruxtecan | Daiichi Sankyo | Phase 1/2 | Recruiting | 39 |
1 competing product in clinical development for Malignant Neoplasm.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Patritumab Deruxtecan | Daiichi Sankyo | Phase 1/2 | Recruiting | 39 |